piracetam has been researched along with Academic Disorder, Developmental in 23 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate the prevalence and psychopathological features of psychiatric adverse events (PAEs) in patients with learning disabilities (LD) in therapy with levetiracetam (LEV)." | 7.72 | Psychiatric adverse events in patients with epilepsy and learning disabilities taking levetiracetam. ( Mula, M; Sander, JW; Trimble, MR, 2004) |
| "The purpose was to evaluate the effects of levetiracetam (LEV) in routine therapy in learning disabled patients with therapy-resistant epilepsy." | 7.72 | Efficacy and tolerability of levetiracetam in patients with therapy-resistant epilepsy and learning disabilities. ( Bömmel, W; Hauser, I; Horstmann, V; Huber, B; Liem, S; May, T; Meinert, T; Robertson, E; Schulz, L; Seidel, M; Tomka-Hoffmeister, M; Wagner, W, 2004) |
| "Levetiracetam was generally well tolerated." | 6.74 | The underrecognized epilepsy spectrum: the effects of levetiracetam on neuropsychological functioning in relation to subclinical spike production. ( Brown, M; Legoff, D; Levin-Allen, S; Mintz, M; Mintz, P; Scornaienchi, J; Smith, C, 2009) |
| "Levetiracetam is a new anticonvulsant (AED) with a novel mechanism of action." | 5.31 | Levetiracetam psychosis in children with epilepsy. ( Bergey, GK; Freeman, JM; Kossoff, EH; Vining, EP, 2001) |
| "To investigate the prevalence and psychopathological features of psychiatric adverse events (PAEs) in patients with learning disabilities (LD) in therapy with levetiracetam (LEV)." | 3.72 | Psychiatric adverse events in patients with epilepsy and learning disabilities taking levetiracetam. ( Mula, M; Sander, JW; Trimble, MR, 2004) |
| "The purpose was to evaluate the effects of levetiracetam (LEV) in routine therapy in learning disabled patients with therapy-resistant epilepsy." | 3.72 | Efficacy and tolerability of levetiracetam in patients with therapy-resistant epilepsy and learning disabilities. ( Bömmel, W; Hauser, I; Horstmann, V; Huber, B; Liem, S; May, T; Meinert, T; Robertson, E; Schulz, L; Seidel, M; Tomka-Hoffmeister, M; Wagner, W, 2004) |
| "Levetiracetam was generally well tolerated." | 2.74 | The underrecognized epilepsy spectrum: the effects of levetiracetam on neuropsychological functioning in relation to subclinical spike production. ( Brown, M; Legoff, D; Levin-Allen, S; Mintz, M; Mintz, P; Scornaienchi, J; Smith, C, 2009) |
| "Piracetam was compared with placebo in a double-blind cross-over study of 30 learning disabled boys." | 2.65 | Effect of piracetam on EEG spectra of boys with learning disorders. ( Cho, D; Reker, D; Simeon, J; Simeon, S; Volavka, J, 1981) |
| "Aniracetam was administered to 1-month-old rats, demonstrating a prolonged (2 months) therapeutic effect, observed in rats aged 3 months." | 1.31 | Can nootropic drugs be effective against the impact of ethanol teratogenicity on cognitive performance? ( Vaglenova, J; Vesselinov Petkov, V, 2001) |
| "Levetiracetam is a new anticonvulsant (AED) with a novel mechanism of action." | 1.31 | Levetiracetam psychosis in children with epilepsy. ( Bergey, GK; Freeman, JM; Kossoff, EH; Vining, EP, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (43.48) | 18.7374 |
| 1990's | 4 (17.39) | 18.2507 |
| 2000's | 7 (30.43) | 29.6817 |
| 2010's | 2 (8.70) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| McNally, MA | 1 |
| Kossoff, EH | 2 |
| Mintz, M | 1 |
| Legoff, D | 1 |
| Scornaienchi, J | 1 |
| Brown, M | 1 |
| Levin-Allen, S | 1 |
| Mintz, P | 1 |
| Smith, C | 1 |
| Sharma, K | 1 |
| Bhatnagar, M | 1 |
| Kulkarni, SK | 1 |
| Mula, M | 1 |
| Trimble, MR | 1 |
| Sander, JW | 1 |
| Huber, B | 1 |
| Bömmel, W | 1 |
| Hauser, I | 1 |
| Horstmann, V | 1 |
| Liem, S | 1 |
| May, T | 1 |
| Meinert, T | 1 |
| Robertson, E | 1 |
| Schulz, L | 1 |
| Seidel, M | 1 |
| Tomka-Hoffmeister, M | 1 |
| Wagner, W | 1 |
| Chappell, B | 1 |
| Crawford, P | 1 |
| Chen, J | 1 |
| Long, Y | 1 |
| Han, M | 1 |
| Wang, T | 1 |
| Chen, Q | 1 |
| Wang, R | 1 |
| Gualtieri, CT | 1 |
| Golden, RN | 1 |
| Fahs, JJ | 1 |
| Volavka, J | 1 |
| Simeon, J | 3 |
| Simeon, S | 1 |
| Cho, D | 1 |
| Reker, D | 1 |
| Waters, B | 2 |
| Resnick, M | 2 |
| Trites, R | 1 |
| Fiedorowicz, C | 1 |
| Trofimov, SS | 3 |
| Ostrovskaia, RU | 2 |
| Kravchenko, EV | 2 |
| Smol'nikova, NM | 2 |
| Bondarenko, NA | 1 |
| Kutepova, OA | 1 |
| Nemova, EP | 2 |
| Voronina, TA | 3 |
| Krylov, IN | 1 |
| Iasnetsov, VV | 1 |
| Dukhanin, AS | 1 |
| Pal'tsev, IuP | 1 |
| Vaglenova, J | 1 |
| Vesselinov Petkov, V | 1 |
| Bergey, GK | 1 |
| Freeman, JM | 1 |
| Vining, EP | 1 |
| Mönikes, HJ | 1 |
| Leary, PM | 2 |
| Machanick, S | 1 |
| Arens, LJ | 1 |
| Rabkin, J | 1 |
| Logue, GD | 1 |
| Garibova, TL | 1 |
| Sopyev, ZhA | 1 |
| Petkov, VD | 1 |
| Lazarova, MB | 1 |
| Wilsher, CR | 1 |
2 reviews available for piracetam and Academic Disorder, Developmental
| Article | Year |
|---|---|
New developments in pediatric psychopharmacology.
Topics: Adolescent; Adult; Aggression; Anorexia Nervosa; Antidepressive Agents, Tricyclic; Autistic Disorder | 1983 |
Effects of piracetam on developmental dyslexia.
Topics: Animals; Cerebral Cortex; Clinical Trials as Topic; Conditioning, Operant; Corpus Callosum; Dogs; Do | 1986 |
5 trials available for piracetam and Academic Disorder, Developmental
| Article | Year |
|---|---|
The underrecognized epilepsy spectrum: the effects of levetiracetam on neuropsychological functioning in relation to subclinical spike production.
Topics: Adolescent; Anticonvulsants; Attention; Attention Deficit and Disruptive Behavior Disorders; Brain; | 2009 |
New developments in pediatric psychopharmacology.
Topics: Adolescent; Adult; Aggression; Anorexia Nervosa; Antidepressive Agents, Tricyclic; Autistic Disorder | 1983 |
Effect of piracetam on EEG spectra of boys with learning disorders.
Topics: Adolescent; Brain; Child; Delta Rhythm; Electroencephalography; Humans; Learning Disabilities; Male; | 1981 |
Letter: Piracetam and pyrithioxine.
Topics: Child; Clinical Trials as Topic; Humans; Learning Disabilities; Piracetam; Placebos; Pyrrolidinones | 1975 |
Effects of piracetam on developmental dyslexia.
Topics: Animals; Cerebral Cortex; Clinical Trials as Topic; Conditioning, Operant; Corpus Callosum; Dogs; Do | 1986 |
18 other studies available for piracetam and Academic Disorder, Developmental
| Article | Year |
|---|---|
Incidental rolandic spikes: long-term outcomes and impact of treatment.
Topics: Anticonvulsants; Child; Child, Preschool; Electroencephalography; Epilepsy, Rolandic; Female; Follow | 2015 |
Effect of Convolvulus pluricaulis Choisy and Asparagus racemosus Willd on learning and memory in young and old mice: a comparative evaluation.
Topics: Acetylcholine; Aging; Animals; Antioxidants; Cholinergic Agents; Convolvulus; Dose-Response Relation | 2010 |
Psychiatric adverse events in patients with epilepsy and learning disabilities taking levetiracetam.
Topics: Adult; Analysis of Variance; Anticonvulsants; Behavioral Symptoms; Chi-Square Distribution; Epilepsy | 2004 |
Efficacy and tolerability of levetiracetam in patients with therapy-resistant epilepsy and learning disabilities.
Topics: Adolescent; Adult; Aged; Epilepsy; Female; Humans; Learning Disabilities; Levetiracetam; Male; Middl | 2004 |
An audit of lamotrigine, levetiracetam and topiramate usage for epilepsy in a district general hospital.
Topics: Adult; Aged; Anticonvulsants; Cohort Studies; Drug Utilization; Epilepsy; Epilepsy, Generalized; Fem | 2005 |
Water-soluble derivative of propolis mitigates scopolamine-induced learning and memory impairment in mice.
Topics: Acetylcholinesterase; Animals; Arginine; Cerebral Cortex; Chromatography, High Pressure Liquid; Hipp | 2008 |
An adverse reaction to piracetam in an hypothyroid 10 year old boy.
Topics: Brain Diseases; Child; Double-Blind Method; Humans; Hypothyroidism; Learning Disabilities; Male; Pir | 1980 |
Effects of piracetam in children with learning disorders.
Topics: Adolescent; Child; Double-Blind Method; Humans; Learning Disabilities; Male; Piracetam; Pyrrolidinon | 1980 |
[Behavior disorders in rats exposed to intrauterine hypoxia, and their correction by postnatal treatment with piracetam].
Topics: Animals; Behavior, Animal; Female; Fetal Hypoxia; Learning Disabilities; Memory Disorders; Piracetam | 1993 |
[Pharmacologic correction of learning and memory disorders induced by exposure to high-frequency electromagnetic radiation].
Topics: Animals; Learning Disabilities; Male; Memory Disorders; Microwaves; Naloxone; Piracetam; Psychotropi | 1993 |
[Piracetam as a corrector of long-term learning disorders caused by prenatal alcohol exposure: the significance of the length of therapy].
Topics: Animals; Avoidance Learning; Ethanol; Female; Learning Disabilities; Male; Nootropic Agents; Piracet | 1996 |
Can nootropic drugs be effective against the impact of ethanol teratogenicity on cognitive performance?
Topics: Alcohol-Induced Disorders, Nervous System; Animals; Disease Models, Animal; Female; Learning Disabil | 2001 |
Levetiracetam psychosis in children with epilepsy.
Topics: Acute Disease; Adolescent; Anticonvulsants; Child, Preschool; Comorbidity; Drug Administration Sched | 2001 |
[Legasthenia. Diagnosis, therapy--experiences in a child and adolescent psychiatric ambulatory].
Topics: Adolescent; Ambulatory Care; Child; Child Behavior Disorders; Dyslexia; Female; Handwriting; Humans; | 1977 |
Piracetam in the management of minimal brain dysfunction.
Topics: Attention Deficit Disorder with Hyperactivity; Child; Humans; Learning Disabilities; Piracetam; Pyrr | 1976 |
Letter: Piracetam and pyrithioxine.
Topics: Animals; Blood-Brain Barrier; Cerebral Cortex; Child; Humans; Learning Disabilities; Piracetam; Pyri | 1975 |
Letter: Pyracetam and pyrithioxine.
Topics: Age Factors; Child; Child, Preschool; Humans; Learning Disabilities; Piracetam; Pyridines; Pyrithiox | 1975 |
Comparative studies on the influence of ONK (N(5-hydroxynicotinoil) glutamic acid), piracetam and meclofenoxate on the learning- and memory-impairing effect of scopolamine, clonidine, and methergoline.
Topics: Animals; Avoidance Learning; Clonidine; Glutamates; Learning Disabilities; Male; Meclofenoxate; Memo | 1991 |